SAN DIEGO--(BUSINESS WIRE)--Ichor Medical Systems, Inc. (Ichor) announced today the first in human dosing of JNJ-64300535 with its next generation investigational TriGrid ® Delivery System. This DNA ...
SAN FRANCISCO & TUALATIN, Ore.--(BUSINESS WIRE)--Francisco Partners, a leading technology-focused private equity firm, today announced the acquisition of Ichor Systems. Based in Tualatin, Ore., Ichor ...
US Department Of Defense Awards Grant to Ichor Medical Systems, Inc. to Evaluate Skin Electroporation Device tor Delivery of Multi-Agent Dna Vaccines April 18, 2011 -- San Diego, CA - Ichor Medical ...
Ichor enters into an agreement with Pfizer to develop next generation TriGrid electroporation devices for use in Pfizer's vaccine-based immunotherapies for cancer indications SAN DIEGO--(BUSINESS WIRE ...
Ichor Medical Systems said it will develop electroporation devices for use in Pfizer's ($PFE) preclinical cancer vaccine research efforts. Neither side is disclosing ...
SAN DIEGO, Apr 13, 2015 (BUSINESS WIRE) -- Ichor Medical Systems, Inc. (Ichor) announced today that it has entered into a product development collaboration and worldwide license agreement with Janssen ...
To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Almost 180 local high-tech and manufacturing employees are ...
Buyout shop Francisco Partners has acquired Ichor Systems, an Oregon-based designer and manufacturer of process tools, gas delivery modules and chemical delivery modules sold to capital equipment ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results